Loading…

NeuroPace (NPCE) backlog: remaining performance obligations

How much revenue NeuroPace already has under contract, how fast it converts, and who it is with.

Data as of .

NeuroPace backlog history

$0$50M$100MMar 2024Sep 2024Mar 2025Sep 2025Mar 2026Jun 2026Backlog (RPO)Trailing 12-month revenue
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter endBacklog (RPO)TTM revenueCoverageCustomer prepayments
30 Jun 2026$1.60M$103M0.0 yrs$100,000
31 Mar 2026$1.90M$99.5M0.0 yrs$100,000
31 Dec 2025$1.50M$100M0.0 yrs$100,000
30 Sep 2025$800,000$90.8M0.0 yrs$600,000
30 Jun 2025$1.60M$84.6M0.0 yrs$700,000
31 Mar 2025$1.80M$84.3M0.0 yrs$700,000
31 Dec 2024$1.70M$79.9M0.0 yrs$600,000
30 Sep 2024$1.90M$76.5M0.0 yrs$700,000
30 Jun 2024$2.10M$71.8M0.0 yrs$800,000
31 Mar 2024$2.20M$69.1M0.0 yrs$900,000

Questions

What is NeuroPace's backlog?
NeuroPace reported $1.60M of remaining performance obligations at 30 Jun 2026, flat from a year earlier and down 16% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.99.

About these numbers

Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.